Rare diseases
Investigational molecules
Locations
Study on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
CzechiaStudy on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
CzechiaStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
CzechiaStudy on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis
CzechiaStudy Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients
CzechiaStudy on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer
CzechiaStudy of Subcutaneous Nivolumab for Patients with Previously Treated Advanced or Metastatic Clear Cell Kidney Cancer
CzechiaStudy of Atezolizumab and Tiragolumab for Patients with Recurrent or Metastatic PD-L1 Positive Head and Neck Squamous Cell Carcinoma
CzechiaStudy on Frexalimab for Patients with Relapsing Multiple Sclerosis
CzechiaStudy on the Safety and Efficacy of MK-0616 for Adults with High Cholesterol
CzechiaStudy of remibrutinib for long-term treatment of adult patients with chronic spontaneous urticaria who completed previous remibrutinib studies
CzechiaStudy of Cabozantinib and Atezolizumab Compared to Hormonal Therapy in Adults with Metastatic Castration-Resistant Prostate Cancer
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.
